Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Immune-transcriptome signatures: a novel approach to understanding GvHD & GvT

Sara Deola, MD, PhD, Sidra Medicine, Doha, Qatar, discusses the results of a longitudinal study of immune-transcriptome signatures as a novel approach to understanding graft-versus-host disease (GvHD) and graft-versus-tumor-effect (GVT). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.